[go: up one dir, main page]

BRPI0818079A8 - Composição de lipídeo - Google Patents

Composição de lipídeo

Info

Publication number
BRPI0818079A8
BRPI0818079A8 BRPI0818079A BRPI0818079A BRPI0818079A8 BR PI0818079 A8 BRPI0818079 A8 BR PI0818079A8 BR PI0818079 A BRPI0818079 A BR PI0818079A BR PI0818079 A BRPI0818079 A BR PI0818079A BR PI0818079 A8 BRPI0818079 A8 BR PI0818079A8
Authority
BR
Brazil
Prior art keywords
lipid composition
composition
maturation
nutritional
differentiation
Prior art date
Application number
BRPI0818079A
Other languages
English (en)
Inventor
Ben Dror Gai
Lifshitz Yael
Bar Yosef Fabiana
Cohen Tzafra
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40445529&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0818079(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of BRPI0818079A2 publication Critical patent/BRPI0818079A2/pt
Publication of BRPI0818079A8 publication Critical patent/BRPI0818079A8/pt
Publication of BRPI0818079B1 publication Critical patent/BRPI0818079B1/pt
Publication of BRPI0818079B8 publication Critical patent/BRPI0818079B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/001—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/003—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/16—Fatty acid esters
    • A21D2/165—Triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

COMPOSIÇÃO DE LIPÍDEO. A presente invenção proporciona o uso de uma composição de lipídeo para a preparação de uma composição nutricional, farmacêutica ou nutracêutica ou um alimento funcional, para a prevenção e o tratamento de distúrbios e doenças gastrointestinais, e para promover desenvolvimento, maturação, adaptação e diferenciação intestinais.
BRPI0818079A 2007-10-09 2008-10-02 composição de lipídeo BRPI0818079B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96066407P 2007-10-09 2007-10-09
PCT/IL2008/001311 WO2009047754A2 (en) 2007-10-09 2008-10-02 Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation

Publications (4)

Publication Number Publication Date
BRPI0818079A2 BRPI0818079A2 (pt) 2017-06-13
BRPI0818079A8 true BRPI0818079A8 (pt) 2017-10-03
BRPI0818079B1 BRPI0818079B1 (pt) 2019-11-05
BRPI0818079B8 BRPI0818079B8 (pt) 2021-07-27

Family

ID=40445529

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818079A BRPI0818079B8 (pt) 2007-10-09 2008-10-02 composição de lipídeo

Country Status (12)

Country Link
US (3) US9107439B2 (pt)
EP (1) EP2207429B2 (pt)
KR (1) KR101354547B1 (pt)
CN (1) CN101896073B (pt)
AU (1) AU2008309140B9 (pt)
BR (1) BRPI0818079B8 (pt)
CA (1) CA2701161C (pt)
DK (1) DK2207429T4 (pt)
ES (1) ES2426591T5 (pt)
MX (1) MX2010003651A (pt)
RU (1) RU2469545C2 (pt)
WO (1) WO2009047754A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101909467B (zh) * 2007-11-01 2013-04-24 恩兹默泰克有限公司 用于婴儿营养的脂质混合物
US9491955B2 (en) 2008-08-25 2016-11-15 Brandeis University Balanced myristate- and laurate-containing edible oil
WO2011071367A1 (en) * 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
SG184349A1 (en) * 2010-04-26 2012-11-29 Enzymotec Ltd Methods and lipid compositions for promoting development of gut flora
DK2658404T3 (da) 2010-12-29 2016-02-08 Abbott Lab Ernæringsprodukter indbefattende et nyt fedtstofsystem indbefattende monoglycerider
KR101680501B1 (ko) * 2012-09-13 2016-11-28 스쁘씨야리떼 뻬 프 시간 경과시 애완동물 사료의 개선된 기호도를 유지시키기 위한 지방 조성물의 용도
DK2956010T4 (da) 2013-02-12 2023-01-09 Bunge Loders Croklaan B V Fedtsammensætning
FI3821713T3 (fi) * 2013-03-13 2025-03-27 Prolacta Bioscience Inc Runsasrasvaisia äidinmaitotuotteita
RU2648375C2 (ru) * 2013-04-10 2018-03-26 Нестек С.А. Детская смесь с низким содержанием жирных кислот со средней длиной цепи в определенных пропорциях и ее применение при стимуляции и/или обеспечении сбалансированного роста грудных детей
EP2991508A1 (en) * 2013-04-10 2016-03-09 Nestec S.A. Infant formula with a low content of mcfas in specific proportions and a relatively high content of unsaturated fatty acids, and its use in promoting the healthy establishment of cognitive function in infants
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
WO2016178221A1 (en) * 2015-05-04 2016-11-10 Enzymotec Ltd. Lipid compositions for improving sleep
WO2017153998A1 (en) * 2016-03-10 2017-09-14 Enzymotec Ltd. Lipid compositions and uses thereof
ES2930351T3 (es) 2016-04-15 2022-12-09 Evive Biotechnology Shanghai Ltd Un dímero de IL-22 para su uso en el tratamiento de enterocolitis necrosante
CN107518382A (zh) * 2016-06-21 2017-12-29 丰益(上海)生物技术研发中心有限公司 一种提升肠道的中短链酸丰度的方法
WO2020229689A1 (en) 2019-05-15 2020-11-19 N.V. Nutricia Fermented formula for improving intestinal development
CN111011864A (zh) * 2019-12-27 2020-04-17 内蒙古蒙牛乳业（集团）股份有限公司 一种促进肠道健康的营养组分
WO2021219634A2 (en) * 2020-04-27 2021-11-04 Société des Produits Nestlé S.A. Method for producing milk like products
CN111700178A (zh) * 2020-06-16 2020-09-25 江南大学 一种罗非鱼油或其分提物的应用
CN115104651A (zh) * 2022-05-05 2022-09-27 上海交通大学 有效改善代谢的油脂组合物及其应用
CN116473132B (zh) * 2023-03-30 2024-02-13 江南大学 一种富含山柚油的组合物、制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2178752B (en) * 1985-07-12 1989-10-11 Unilever Plc Substitute milk fat
US4753963A (en) 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
ES2107663T3 (es) † 1992-04-28 1997-12-01 Fresenius Ag Empleo de una emulsion que contiene acidos grasos omega-3 en la fabricacion de un medicamento a administrar por via parenteral para el tratamiento de las enfermedades inflamatorias.
WO1994026855A1 (en) * 1993-05-13 1994-11-24 Loders-Croklaan Human milk fat replacers from interesterified blends of triglycerides
ID22744A (id) * 1997-02-21 1999-12-09 Abbott Lab Cs Metoda dan komposisi untuk mengurangi pengaruh dari nekrotisasi enterkolitis
ATE230935T1 (de) * 1997-07-22 2003-02-15 Nestle Sa Lipidzusammensetzung für säuglingsnährpräparat und herstellungsverfahren
JP4175698B2 (ja) 1998-06-19 2008-11-05 サントリー株式会社 新規なトリグリセリド及びそれを含む組成物
EP1034704A1 (en) † 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
EP1062873A1 (en) † 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
IL158555A0 (en) † 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
KR101368603B1 (ko) 2005-04-27 2014-02-27 엔지모테크 리미티드 모유 지방 대체물
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007058523A1 (en) † 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
WO2007088160A1 (en) † 2006-01-31 2007-08-09 Nestec S.A. Nutritional composition for low birth weight infants
US9254275B2 (en) † 2007-09-17 2016-02-09 Cornell University Branched chain fatty acids for prevention or treatment of gastrointestinal disorders
EP2143340A1 (en) 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids

Also Published As

Publication number Publication date
DK2207429T3 (da) 2013-09-08
EP2207429A2 (en) 2010-07-21
US20100273881A1 (en) 2010-10-28
CN101896073B (zh) 2013-11-20
EP2207429B1 (en) 2013-06-05
BRPI0818079B1 (pt) 2019-11-05
US8980949B2 (en) 2015-03-17
RU2010117211A (ru) 2011-11-20
KR101354547B1 (ko) 2014-01-22
WO2009047754A3 (en) 2009-05-22
US9107439B2 (en) 2015-08-18
EP2207429B2 (en) 2016-12-28
ES2426591T5 (es) 2017-08-16
ES2426591T3 (es) 2013-10-24
AU2008309140B9 (en) 2013-07-04
MX2010003651A (es) 2010-07-05
CA2701161A1 (en) 2009-04-16
US20160030377A1 (en) 2016-02-04
BRPI0818079A2 (pt) 2017-06-13
WO2009047754A2 (en) 2009-04-16
AU2008309140A1 (en) 2009-04-16
CN101896073A (zh) 2010-11-24
US9561207B2 (en) 2017-02-07
KR20100106951A (ko) 2010-10-04
US20140187632A1 (en) 2014-07-03
RU2469545C2 (ru) 2012-12-20
CA2701161C (en) 2014-01-14
BRPI0818079B8 (pt) 2021-07-27
DK2207429T4 (en) 2017-04-10
AU2008309140B2 (en) 2013-05-09

Similar Documents

Publication Publication Date Title
BRPI0818079B8 (pt) composição de lipídeo
IL204886B (en) A pharmaceutical preparation for the treatment of disorders of the stomach and intestines independent of food consumption
BRPI0717697A2 (pt) composto, composição farmaceutica, uso do composto, método para tratar um paciente sofrendo de uma condição patológica ou uma doença e combinação de produtos
EP3050876A3 (en) Kinase modulators
BRPI0910184A2 (pt) "preparação de uma mistura derivada de não mamíferos de conjugados de glicerofosfolipídio de soro, método de melhoria de uma condição em um paciente que sofre de doença ou distúrbio cognitivo, uso de uma preparação, composição nutricional, farmacêutica ou nutracêutica ou alimento funcional"
PA8770101A1 (es) Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso
BRPI0716985A2 (pt) Composição nutricional, uso da mesma, e, suplemento nutricional para o tratamento de pacientes que sofrem de alergias a alimentos
BRPI1005153A2 (pt) composto, composição farmacêutica, uso de um composto, metodo para tratar um indivíduo que sofre de uma condição patológica ou doença e produto de combinação
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BR112012001297A2 (pt) conector.
WO2012083017A3 (en) Controlled release oral dosage forms of poorly soluble drugs and uses thereof
BRPI0616962B8 (pt) uso de lactobacillus para o tratamento de doenças autoimunes
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
PT2131680E (pt) Probióticos para melhorar a microflora intestinal
BRPI0816320A2 (pt) Composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto de combinação, e, processos para a preparação deu um composto, de uma formulação farmacêutica, e de um produto de combinação
MA33075B1 (fr) Composition destinee a la regulation du metabolism des lipides
BR112012002265A2 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
NO20085374L (no) Anvendelse av fytat som middel for a inhibere opplosning av krystaller av kalsiumsalter for forhindring av osteoporose
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
WO2011128627A8 (en) Oral veterinary pharmaceutical and nutraceutical compositions
WO2008054808A3 (en) Elvucitabine pharmaceutical compositions
PA8781501A1 (es) Formulacion de pasireotida
WO2009068708A3 (es) Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/115 (2016.01), A23D 7/00 (1990.01), A21D 2

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/11/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/10/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B22B Petition not considered [chapter 22.2 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 870210088911, DE 27/09/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2743 DE 01-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.